GSK PLC Director/PDMR Shareholding (0493A)
2024年1月18日 - 12:30AM
ＲＮＳを含む英国規制内ニュース （英語）
TIDMGSK
RNS Number : 0493A
GSK PLC
17 January 2024
GSK plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Emma Walmsley
==== ====================================== ======================================================
b) Position/status Chief Executive Officer
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 11 January 2024
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP15.5640 467
======================================================================= ======================
GBP15.5640 699
======================================================================= ======================
GBP15.5640 1,161
======================================================================= ======================
d) Aggregated information
====
Aggregated volume 2,327
Price GBP15.5640
====================================== ===========================================================
e) Date of the transaction 2024-01-15
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Dr Hal Barron
==== ======================================== ====================================================
b) Position/status Non-Executive Director
==== ======================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ======================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial
instrument ISIN: US37733W2044
==== ======================================== ====================================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 11 January 2024 on ADSs
held in the Company's Deferred Annual Bonus
Plan
==== ======================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ====================== =========================
$39.6400 231
---------------------- -------------------------
$39.6400 365
---------------------- -------------------------
d) Aggregated information
====
Aggregated volume 596
Price
$39.6400
==================================================================================================
e) Date of the transaction 2024-01-15
==== ======================================== ====================================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Diana Conrad
==== ====================================== ======================================================
b) Position/status Chief People Officer
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 11 January 2024
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP15.5640 67
======================================================================= ======================
GBP15.5640 109
======================================================================= ======================
GBP15.5640 211
======================================================================= ======================
d) Aggregated information
====
Aggregated volume 387
Price GBP15.5640
====================================== ===========================================================
e) Date of the transaction 2024-01-15
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name James Ford
==== ====================================== ======================================================
b) Position/status SVP and Group General Counsel, Legal and
Compliance
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 11 January 2024
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP15.5640 81
======================================================================= ======================
GBP15.5640 135
======================================================================= ======================
GBP15.5640 205
======================================================================= ======================
d) Aggregated information
====
Aggregated volume 421
Price GBP15.5640
====================================== ===========================================================
e) Date of the transaction 2024-01-15
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Sally Jackson
==== ====================================== ======================================================
b) Position/status SVP, Global Communications and CEO Office
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 11 January 2024
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP15.5640 41
======================================================================= ======================
GBP15.5640 63
======================================================================= ======================
GBP15.5640 127
======================================================================= ======================
d) Aggregated information
====
Aggregated volume 231
Price GBP15.5640
====================================== ===========================================================
e) Date of the transaction 2024-01-15
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Luke Miels
==== ====================================== ======================================================
b) Position/status Chief Commercial Officer
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 11 January 2024
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP15.5640 126
======================================================================= ======================
GBP15.5640 229
======================================================================= ======================
GBP15.5640 495
======================================================================= ======================
d) Aggregated information
====
Aggregated volume 850
Price GBP15.5640
====================================== ===========================================================
e) Date of the transaction 2024-01-15
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Shobie Ramakrishnan
==== ======================================== ====================================================
b) Position/status Chief Digital and Technology Officer
==== ======================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ======================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial
instrument ISIN: US37733W2044
==== ======================================== ====================================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 11 January 2024 on ADSs
held in the Company's Deferred Annual Bonus
Plan
==== ======================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ====================== =========================
$39.6400 22
====================== =========================
$39.6400 96
====================== =========================
d) Aggregated information
====
Aggregated volume 118
Price
$39.6400
==================================================================================================
e) Date of the transaction 2024-01-15
==== ======================================== ====================================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name David Redfern
==== ====================================== ======================================================
b) Position/status President Corporate Development
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 11 January 2024
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP15.5640 99
======================================================================= ======================
GBP15.5640 152
======================================================================= ======================
GBP15.5640 286
======================================================================= ======================
d) Aggregated information
====
Aggregated volume 537
Price GBP15.5640
====================================== ===========================================================
e) Date of the transaction 2024-01-15
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Regis Simard
==== ====================================== ======================================================
b) Position/status President, Global Supply Chain
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 11 January 2024
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP15.5640 75
======================================================================= ======================
GBP15.5640 138
======================================================================= ======================
GBP15.5640 230
======================================================================= ======================
d) Aggregated information
====
Aggregated volume 443
Price GBP15.5640
====================================== ===========================================================
e) Date of the transaction 2024-01-15
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Phil Thomson
==== ====================================== ======================================================
b) Position/status President, Global Affairs
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 11 January 2024
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP15.5640 58
======================================================================= ======================
GBP15.5640 96
======================================================================= ======================
GBP15.5640 150
======================================================================= ======================
d) Aggregated information
====
Aggregated volume 304
Price GBP15.5640
====================================== ===========================================================
e) Date of the transaction 2024-01-15
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Deborah Waterhouse
==== ====================================== ======================================================
b) Position/status CEO, ViiV Healthcare and President, Global
Health, GSK
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 11 January 2024
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP15.5640 119
======================================================================= ======================
GBP15.5640 101
======================================================================= ======================
GBP15.5640 366
======================================================================= ======================
d) Aggregated information
====
Aggregated volume 586
Price GBP15.5640
====================================== ===========================================================
e) Date of the transaction 2024-01-15
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Tony Wood
==== ====================================== ======================================================
b) Position/status Chief Scientific Officer
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 11 January 2024
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=========================== ======================
GBP15.5640 173
----------------------------------------------------------------------- ----------------------
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
==================================================================== =============================
e) Date of the transaction 2024-01-15
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==========================================================================
a) Name Emma Walmsley
=== ======================== ================================================
b) Position/status Chief Executive Officer
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GSK plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
=== ======================== ================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 11 January 2024 on Ordinary
Shares held in the Company's Performance
Share Plan subject to a 2-year holding
period
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP15.5640 4947.304
----------
=== ======================== ================================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ======================== ================================================
e) Date of the transaction 2024-01-15
=== ======================== ================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHSFSFIWELSEFF
(END) Dow Jones Newswires
January 17, 2024 10:30 ET (15:30 GMT)
Gsk (LSE:GSK)
過去 株価チャート
から 6 2024 まで 7 2024
Gsk (LSE:GSK)
過去 株価チャート
から 7 2023 まで 7 2024
